Correction to: Oncogene (2017) 36, 746–755; doi:10.1038/onc.2016.243; published online 25 July 2016
In Figure 2c, the label above the middle panel in this paper was published incorrectly. The correct label should read BRCA1−/− instead of BRCA2−/−.
The corrected figure 2 is below.
The publishers wish to apologise for any inconvenience caused.
Additional information
The online version of the original article can be found at 10.1038/onc.2016.243
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Zámborszky, J., Szikriszt, B., Gervai, J. et al. Erratum: Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions. Oncogene 36, 5085–5086 (2017). https://doi.org/10.1038/onc.2017.213
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2017.213
This article is cited by
-
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster
Nature Medicine (2022)
-
Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020
Cancer and Metastasis Reviews (2021)
-
Mutational signatures: experimental design and analytical framework
Genome Biology (2020)
-
Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor
Nature Communications (2020)